Systems Biology of Amyotrophic Lateral Sclerosis (ALS)

The goal of this observational study is to identify molecular features in multiple clinical samples and/or the patient environment that are associated with ALS. Participants will collect biological samples and answer questionnaires regarding their health at each appointment with their ALS practitioner.

NCT Number	NCT07007390
Lead Sponsor	Viome Collaborators: Universidade Federal de Santa Catarina
Conditions	ALS, ALS (Amyotrophic Lateral Sclerosis)
Enrollment	20 participants
Start Date	2025-06-01
Primary Completion	2030-02-01 (estimated)
Study Completion	2030-05-01 (estimated)
Updated on ClinicalTrials.gov	2025-06-05